BLOG

Immunomedics nabs J&J veteran for CMO as it presses on with ADC redo

For the last year, biopharma veteran Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate, sacituzumab govitecan. Now, she’s signing on with the company full-time as its new chief medical officer.